Nigella 5 in the Treatment of SARS COV2 (COVID-19)

NCT04914767 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV2 Infection

Interventions

DRUG: Nigella
DRUG: Placebo

Sponsor

Hôpital Universitaire Sahloul